Trump Imposes New Tariffs On Patented Pharma Imports
Trump has imposed tariffs on patented pharma imports to encourage US-based production, citing national security. Generic medicines, largely exported by India, remain exempt for now, protecting 90% of Indian pharma exports. Long-term effects may hit global supply chains, contract manufacturing, and active ingredient supplies to multinational companies.